AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 155 filers reported holding AMNEAL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $79,104 | -48.7% | 18,745 | -63.1% | 0.00% | – |
| Q2 2023 | $154,250 | +97.3% | 50,805 | -9.7% | 0.00% | – |
| Q1 2023 | $78,186 | -29.6% | 56,250 | +1.5% | 0.00% | – |
| Q4 2022 | $111,000 | -5.9% | 55,399 | -5.3% | 0.00% | – |
| Q3 2022 | $118,000 | -38.5% | 58,490 | +0.0% | 0.00% | – |
| Q2 2022 | $192,000 | +51.2% | 58,487 | -0.0% | 0.00% | – |
| Q1 2022 | $127,000 | -55.0% | 58,489 | +0.2% | 0.00% | -100.0% |
| Q4 2021 | $282,000 | -8.7% | 58,355 | +3.5% | 0.00% | 0.0% |
| Q3 2021 | $309,000 | +9.2% | 56,356 | +4.4% | 0.00% | 0.0% |
| Q2 2021 | $283,000 | +1.1% | 53,994 | +27.5% | 0.00% | 0.0% |
| Q1 2021 | $280,000 | +67.7% | 42,357 | +16.0% | 0.00% | – |
| Q4 2020 | $167,000 | -25.1% | 36,521 | -24.3% | 0.00% | -100.0% |
| Q3 2020 | $223,000 | -2.2% | 48,223 | +0.3% | 0.00% | 0.0% |
| Q2 2020 | $228,000 | +68.9% | 48,082 | +13.4% | 0.00% | 0.0% |
| Q1 2020 | $135,000 | – | 42,384 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $144,839,000 | 11.40% |
| Eversept Partners, LP | 4,755,480 | $32,004,380 | 2.41% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $109,116,000 | 1.27% |
| EAM Global Investors LLC | 365,719 | $2,461,000 | 0.68% |
| Signature Wealth Management Partners, LLC | 87,666 | $590,000 | 0.57% |
| Jackson Creek Investment Advisors LLC | 221,043 | $1,488,000 | 0.52% |
| Tranquilli Financial Advisor LLC | 71,414 | $481,000 | 0.39% |
| Hillsdale Investment Management Inc. | 611,200 | $4,113,000 | 0.34% |
| EAM Investors, LLC | 259,873 | $1,749,000 | 0.26% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 180,000 | $1,211,000 | 0.25% |